Related Experiment Video
Updated: Jul 17, 2026
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Severity of Clostridium difficile-associated disease (CDAD) in allogeneic stem cell transplant recipients: evaluation
Erik R Dubberke1, Justin Sadhu, Robert Gatti
1Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA. edubberk@im.wustl.edu
Abstract:
The purpose of this study was to develop and test a Clostridium difficile-associated disease (CDAD) grading system based on presenting symptoms in allogeneic stem cell transplant recipients. Patients with severe CDAD had significantly shorter median survival times and more adverse outcomes than patients with mild or moderate CDAD.
More Related Videos
09:50Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
Published on: February 11, 2019
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018